# Search for marker proteins to assess blood–brain barrier development

**Authors:** Yukari Shigemoto-Mogami, Kimiko Nakayama-Kitamura, Kaoru Sato

PMC · DOI: 10.3389/fnana.2026.1717532 · Frontiers in Neuroanatomy · 2026-02-24

## TL;DR

This study identifies marker proteins that can help assess the development and maturation of the blood–brain barrier in mice.

## Contribution

The paper introduces a classification of proteins based on their temporal expression patterns during BBB development.

## Key findings

- Proteins were grouped into five categories based on their expression during postnatal BBB maturation.
- Representative proteins from each group can indicate the developmental stage of the BBB.
- The findings can improve the design and evaluation of BBB-mimicking microphysiological systems.

## Abstract

The blood–brain barrier (BBB) separates the central nervous system from the peripheral blood circulation, and performs various functions such as dictating central nervous system (CNS)-specific pharmacokinetics, and maintaining brain homeostasis. While previous studies have clarified the mechanisms underlying cerebrovascular network development, details regarding in vivo BBB maturation remain unknown. In this regard, we previously reported that the development of physical tightness of the BBB and the formation of perivascular glial structures begins on postnatal day 4 and is almost complete by postnatal day 15. Moreover, the difficulty in predicting BBB permeability has hindered the development of CNS drugs, and microphysiological systems (MPSs) that mimic the BBB have been extensively developed to address this issue. Building on this information, in this study, we examined the temporal expression patterns of vascular proteins (CD31, Tie2, CD34, CD146, and agrin), tight junction proteins (ZO-1, claudin-5, and occludin), transporters (P-gp, BCRP, and Glut1), and transferrin receptors (TfRs) during the postnatal period, along with the development of BBB tightness. Based on their temporal expression patterns, these proteins were divided into five groups. We selected representative proteins from groups 1–5, respectively, and examined the temporal expression changes to determine the developmental stage of the BBB. The expression patterns of these proteins can be used to determine the maturation stage of BBB-MPSs.

## Linked entities

- **Proteins:** PECAM1 (platelet and endothelial cell adhesion molecule 1), TEK (TEK receptor tyrosine kinase), CD34 (CD34 molecule), MCAM (melanoma cell adhesion molecule), AGRN (agrin), TJP1 (tight junction protein 1), cldn5.L (claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) L homeolog), si:ch73-61d6.3 (uncharacterized si:ch73-61d6.3), PGP (phosphoglycolate phosphatase), ABCG2 (ATP binding cassette subfamily G member 2 (JR blood group)), SLC2A1 (solute carrier family 2 member 1)

## Full-text entities

- **Genes:** TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, MCAM (melanoma cell adhesion molecule) [NCBI Gene 4162] {aka CD146, HEMCAM, METCAM, MUC18, MelCAM}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, BCRP1 (BCR pseudogene 1) [NCBI Gene 644079] {aka BCR-1}, PGP (phosphoglycolate phosphatase) [NCBI Gene 283871] {aka AUM, G3PP, PGPase}, TEK (TEK receptor tyrosine kinase) [NCBI Gene 7010] {aka CD202B, GLC3E, TIE-2, TIE2, VMCM, VMCM1}, CD34 (CD34 molecule) [NCBI Gene 947], CLDN5 (claudin 5) [NCBI Gene 7122] {aka AWAL, BEC1, CPETRL1, TMDVCF, TMVCF}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, AGRN (agrin) [NCBI Gene 375790] {aka AGRIN, CMS8, CMSPPD}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12971911/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12971911/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12971911/full.md

---
Source: https://tomesphere.com/paper/PMC12971911